In The News
Fierce Healthcare
Andrew J. Twinamatsiko
In The News
POLITICO
Zachary L. Baron
DOJ responds to pharma’s IRA tax complaint
Press Release
In The News
Bloomberg Law
Zachary L. Baron
Amgen’s Wezlana Adds Legal Obstacles to Drug Pricing Battle
In The News
Bloomberg Law
Zachary L. Baron
Agencies Will Appeal No Surprises Act Ruling to 5th Circuit
In The News
AIS Health
In The News
Politico
Zachary L. Baron
CMS wants Part D plans to be on their best behavior
In The News
Law360
Zachary L. Baron
Ruling Casts Shadow On Health Plans’ Drug Coupon Policies
In The News
Axios
In The News
Roll Call
Andrew J. Twinamatsiko
Tensions high as Medicare drug negotiations advance
In The News
The Washington Post
Andrew J. Twinamatsiko
The Health 202: The Supreme Court cases we’re watching this term
In The News
STAT
In The News
The New York Sun
In The News
MedPage Today
In The News
Axios
Zachary L. Baron
Legal battle over drug negotiations could collide with 2024 race
In The News
Fierce Healthcare
In The News
Bloomberg Law
Andrew J. Twinamatsiko
Pharma’s Procedural Attack Opens New Front in Drug Price War
In The News
Axios
Zachary L. Baron
Biden admin previews defense of drug price negotiations
In The News
Health Payer Specialist
In The News
Bloomberg Law
Andrew J. Twinamatsiko
Drugs Up for Medicare Price Cuts Fuel Drugmakers’ Legal Strategy
In The News
Bloomberg Law
Zachary L. Baron
Rulings in Medical Billing Suits Create Fallout, Frustration
In The News
Endpoint News
Zachary L. Baron
Legal experts say some IRA challenges are ‘weaker than others’
In The News
MM+M
In The News
Bloomberg Law
Zachary L. Baron